[lwp_divi_breadcrumbs home_text=”Inicio” font_icon=”5||divi||400″ link_color=”#4677F7″ separator_color=”#4677F7″ current_text_color=”#2D4456″ _builder_version=”4.13.1″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][/lwp_divi_breadcrumbs]
FDA APPROVES FIRST DRUG THAT CAN DELAY ONSET OF TYPE 1 DIABETES

FDA APPROVES FIRST DRUG THAT CAN DELAY ONSET OF TYPE 1 DIABETES

The U.S. FDA (1) Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes. “Today’s approval of a first-in-class...